The pharmaceutical industry is expanding rapidly, driven by increasing demand for tailored medicines, growing investments in drug research, and strong government initiatives. Technological advancements such as artificial intelligence and genomics, which allow for more efficient medication discovery and development, are also contributing to this rise.
Given this backdrop, investors could consider buying fundamentally strong pharmaceutical stocks such as Bayer Aktiengesellschaft (BAYRY), Procaps Group S.A. (PROC), ACADIA Pharmaceuticals Inc. (ACAD), and Zoetis Inc. (ZTS).
